The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

CoroNovative BV is wagering that company co-founder Albert Osterhaus, PhD--who has a worldwide reputation as an expert on viruses--and the team assembling around him will make a habit of identifying new pathogens, and so provide the organization with intellectual property supportive of novel vaccines, diagnostics and treatments.